{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:01:35Z","timestamp":1790607695217,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272716"],"award-info":[{"award-number":["81272716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872067"],"award-info":[{"award-number":["81872067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.biopha.2020.109961","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T07:10:17Z","timestamp":1580713817000},"page":"109961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"125","author":[{"given":"Bing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.109961_bib0005","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2020.109961_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jso.23940","article-title":"Differences in gastric cancer survival between the U.S. and China","volume":"112","author":"Strong","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2020.109961_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13304-018-0539-z","article-title":"Multimodal treatment in locally advanced gastric cancer","volume":"70","author":"Goetze","year":"2018","journal-title":"Updates Surg."},{"key":"10.1016\/j.biopha.2020.109961_bib0020","doi-asserted-by":"crossref","first-page":"59950","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2020.109961_bib0025","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.7150\/jca.25236","article-title":"Long non-coding RNA CDKN2B antisense RNA 1 gene inhibits Gemcitabine sensitivity in bladder urothelial carcinoma","volume":"9","author":"Xie","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2020.109961_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00280-019-03873-8","article-title":"Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer","volume":"84","author":"Li","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109961_bib0035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00280-018-3522-y","article-title":"Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma","volume":"81","author":"Shang","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109961_bib0040","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biopha.2018.01.130","article-title":"Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361","volume":"99","author":"Wu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.109961_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00280-016-3194-4","article-title":"Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma","volume":"79","author":"Zhang","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109961_bib0050","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00280-016-3029-3","article-title":"Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer","volume":"77","author":"Shang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109961_bib0055","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1002\/jcp.26813","article-title":"Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21)","volume":"233","author":"Bi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2020.109961_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109342","article-title":"FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer","volume":"118","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.109961_bib0065","first-page":"4656","article-title":"Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer","volume":"23","author":"Gong","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.109961_bib0070","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1002\/jcb.27758","article-title":"FAM83H-AS1 is associated with clinical progression and modulates cell proliferation, migration, and invasion in bladder cancer","volume":"120","author":"Shan","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2020.109961_bib0075","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1038\/s41598-019-40094-8","article-title":"Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells","volume":"9","author":"Barr","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.109961_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152616","article-title":"Upregulation of the long non-coding RNA FAM83H-AS1 in gastric cancer and its clinical significance","volume":"215","author":"Da","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.biopha.2020.109961_bib0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12253-017-0263-x","article-title":"MiR-16-1 targeted silences far upstream element binding protein 1 to advance the chemosensitivity to adriamycin in gastric Cancer","volume":"24","author":"Zhao","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biopha.2020.109961_bib0090","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7150\/jca.29517","article-title":"Knockdown of long non-coding RNA SNHG5 inhibits malignant cellular phenotypes of glioma via Wnt\/CTNNB1 signaling pathway","volume":"10","author":"Hu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2020.109961_bib0095","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.7150\/jca.30877","article-title":"Recent progress in characterizing long noncoding RNAs in Cancer drug resistance","volume":"10","author":"Zhao","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2020.109961_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091015","article-title":"Long non-coding RNA in the pathogenesis of cancers","volume":"8","author":"Chi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2020.109961_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","article-title":"The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2020.109961_bib0110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41419-018-1090-z","article-title":"Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21\/SOCS6 axis","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2020.109961_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12253-017-0233-3","article-title":"Silence of long noncoding RNA NEAT1 inhibits malignant biological behaviors and chemotherapy resistance in gastric Cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biopha.2020.109961_bib0120","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.2147\/OTT.S110055","article-title":"Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer","volume":"9","author":"Yang","year":"2016","journal-title":"Onco. Ther."},{"key":"10.1016\/j.biopha.2020.109961_bib0125","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin Signaling, Disease, and Emerging Therapeutic Modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2020.109961_bib0130","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.7150\/ijbs.27977","article-title":"The roles of Wnt\/\u03b2-catenin signaling pathway related lncRNAs in cancer","volume":"14","author":"Hu","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2020.109961_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5527\/wjn.v8.i5.83","article-title":"WNT\/\u03b2-catenin signaling in urothelial carcinoma of bladder","volume":"8","author":"Garg","year":"2019","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.biopha.2020.109961_bib0140","first-page":"4490","article-title":"The Wnt\/\u03b2-catenin signaling pathway mechanism for pancreatic cancer chemoresistance in a three-dimensional cancer microenvironment","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2020.109961_bib0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11626-019-00360-5","article-title":"BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt\/\u03b2-catenin signaling, in Vitro Cell Dev","volume":"55","author":"Yang","year":"2019","journal-title":"Biol. Anim."},{"key":"10.1016\/j.biopha.2020.109961_bib0150","first-page":"7855","article-title":"Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt\/\u03b2-catenin pathway","volume":"23","author":"Ma","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:52:01Z","timestamp":1790607121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220301517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":30,"alternative-id":["S0753332220301517"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109961","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109961"}}